Lepu Biopharma Co., Ltd. (stock code: 02157) reported that as of 28 February 2026, its authorized share capital remained at 1.80 billion shares, each with a par value of RMB1, totaling RMB1.80 billion. The issued share capital was also unchanged at 1.80 billion shares, with zero shares held as treasury and a maintained public float of 25.00%.

No activity was recorded for share options, warrants, convertible instruments, or other agreements to issue shares during the reporting period. The company confirmed compliance with applicable listing and regulatory requirements.